These final results, together with a former report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 support the idea of concentrating on ACKR3 as a novel solution to modulate the opioid method, which could open up new therapeutic avenues for opioid-relevant disorders. At that time, https://michaelj495ewm4.blogspothub.com/profile